BIOM is moving up after some news today.<g>
EDMONTON, Feb. 6 /PRNewswire-FirstCall/ - Biomira Inc. (Nasdaq: BIOM - News; TSX: BRA - News) announced today that Alex McPherson, MD, PhD, President and CEO of Biomira, will present highlights of the Company's product and corporate advancements at the fifth annual Biotechnology Industry Organization's CEO and Investor Conference at the Waldorf-Astoria, in New York City, on Wednesday, February 26 at 10:00 a.m. EST.
This presentation will be Web cast and available through a link at www.biomira.com.
"This year will be a major milestone in our development.
Towards mid-2003 we anticipate being in a position to announce the results of our Phase III THERATOPE® vaccine trial being tested in women with metastatic breast cancer.
This is believed to be the largest trial ever conducted in the world using an immunotherapeutic to treat this disease," said Alex, McPherson, MD, PhD, President and CEO of Biomira Inc.
The trial was conducted in approximately 120 sites in North America, Europe, Australia, and New Zealand. The final analysis is event driven, based on a certain number of clinical events occurring which will trigger this analysis.
The presentation will also highlight upcoming clinical trial milestones expected in Biomira's Phase II THERATOPE® vaccine study in colorectal cancer and additional clinical milestones expected in BLP25 Liposomal vaccine in both a Phase IIb study in metastatic lung cancer and a Phase II study in prostate study.
All results are expected in 2003. Also discussed will be Biomira's growth potential and the strong and established corporate alliance with Merck KGaA of Darmstadt, Germany.
Dr. McPherson is a board member of the Biotechnology Industry Organization, which is a Washington, D.C.-based organization that engages in lobbying, advocacy, communications and new business development related to the biotech industry. Established in 1993, today it includes more than 1,000 companies, academic institutions and state biotech centers in all 50 U.S. states and 33 other nations.
The goal of the CEO and Investor Conference is to provide a unique and neutral forum where CEOs from small, medium and large cap public companies and private firms planning to go public can interact with investors and other members of the financial community and the healthcare industry.
Dr. McPherson will also be co-chairing the 1st Annual BioPartnering North America (BPN) Conference at the Westin Bayshore Resort and Marina in Vancouver, B.C. on February 9-11, 2003. BPN is the North American version of the distinguished BioPartnering Europe conference held in London each October. Besides co-chairing the event, Dr. McPherson will participate in a panel discussion on February 10, 2003 entitled, "Designing the Biotech Company of the Future." Additional information on the conference can be found at www.techvision.com/bpn/about.html.
Snip
Bernard |
